These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Generic vs. brand name drugs--patients, pharmacists, physicians: caught in the middle. Felch WC Internist; 1979 May; 20(4):3-5. PubMed ID: 10242131 [No Abstract] [Full Text] [Related]
5. The cases for and against prescribing generic drugs: generic prescribing benefits patients. Collier J BMJ; 1988 Dec; 297(6663):1596, 1598. PubMed ID: 3147089 [No Abstract] [Full Text] [Related]
6. Generic acrimony. Dunea G Br Med J; 1979 Jul; 2(6181):31-2. PubMed ID: 466259 [No Abstract] [Full Text] [Related]
7. What use is generic prescribing? Archer M J R Coll Gen Pract; 1985 Jun; 35(275):293-5. PubMed ID: 4032358 [TBL] [Abstract][Full Text] [Related]
8. Brand versus generic prescribing: a perspective of the Indian cardiologists' viewpoint. Bansinath M; Sequeira RP; Shukla VK; Mathur VS Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):279-83. PubMed ID: 6746151 [TBL] [Abstract][Full Text] [Related]
9. [Generic drugs and the rights of substitution]. Vallée JP Presse Med; 1999 Mar; 28(10):535-8. PubMed ID: 10209545 [TBL] [Abstract][Full Text] [Related]
10. Generic drugs and the elderly: another view. Lamy PP J Am Geriatr Soc; 1984 Feb; 32(2):92-4. PubMed ID: 6693709 [No Abstract] [Full Text] [Related]
11. American Academy of Pediatrics Committee on Drugs: Generic prescribing, generic substitution, and therapeutic substitution. Pediatrics; 1987 May; 79(5):835. PubMed ID: 3575043 [No Abstract] [Full Text] [Related]
12. Trade names and generic names. Problems for prescribing physicians. Hemminki E; Enlund H; Hellevuo K; Laurila R; Turakka H Scand J Prim Health Care; 1984 May; 2(2):84-7. PubMed ID: 6544453 [TBL] [Abstract][Full Text] [Related]
13. Editorial: Standardization of drug names--a commentary. Lee A JAMA; 1974 Jul; 229(5):560-2. PubMed ID: 4406903 [No Abstract] [Full Text] [Related]
14. Trade names or proper names? A problem for the prescriber. Huskisson EC Br Med J; 1973 Oct; 4(5886):225-8. PubMed ID: 4758398 [No Abstract] [Full Text] [Related]
15. Trade names or approved names. Part II. Points of view. The pharmaceutical company. Hoare RG Postgrad Med J; 1974 Feb; 50(580):85-7. PubMed ID: 4465781 [TBL] [Abstract][Full Text] [Related]
16. Consumer price differentials between generic and brand name prescriptions. Gumbhir AK; Rodowskas CA Am J Public Health; 1974 Oct; 64(10):977-82. PubMed ID: 4213009 [No Abstract] [Full Text] [Related]
17. States moving to allow generic substitution. Internist; 1979 May; 20(4):12-3. PubMed ID: 10242129 [No Abstract] [Full Text] [Related]
18. Prescription prices under the New York generic substitution law. Francetić I; Lasagna L; Weintraub M; Karch FE Ann Intern Med; 1980 Mar; 92(3):419-23. PubMed ID: 7356236 [TBL] [Abstract][Full Text] [Related]
19. [Generic drugs instead of brand drugs prescriptions--long overdue]. Nelson S; Slørdal L; Spigset O Tidsskr Nor Laegeforen; 2006 Feb; 126(4):441-3. PubMed ID: 16477280 [TBL] [Abstract][Full Text] [Related]
20. Generic drugs provide no big savings so far in nation's health bill. Lublin JS; Jaroslovsky R Wall St J Midwest Ed; 1978 Dec; 59(38):1, 19. PubMed ID: 10239001 [No Abstract] [Full Text] [Related] [Next] [New Search]